Skip to main content
. 2022 Jan 31;41(3):511–518. doi: 10.14366/usg.21237

Table 2.

Pathological diagnoses of the 592 adnexal masses

Pathology No. (%)
Benign masses 447 (75.5)
Mature teratoma 203 (34.3)
Ovarian endometrial cyst 73 (12.3)
Serous cystadenoma and mucinous cystadenoma 63 (10.6)
Ovarian cyst and embryonic residual cyst 43 (7.3)
Adnexal inflammatory mass 42 (7.1)
Other benign tumors 17 (2.9)
Benign mixture ovarian tumor 6 (1.0)
Malignant masses 145 (24.5)
Serous cystadenocarcinoma and mucinous cystadenocarcinoma 80 (13.5)
Other malignant tumors 23 (4.0)
Borderline cystadenoma 21 (3.5)
Endometrioid adenocarcinoma 6 (1.0)
Yolk sac tumor 6 (1.0)
Immature teratoma and Malignant transformation of mature cystic teratoma 5 (0.8)
Dysgerminoma 2 (0.3)
Malignant mixed germ cell tumor 1 (0.2)
Borderline Brenner tumor 1 (0.2)